The proposal must target imminent development of clinical treatments through clinical studies, or clinical trials.
Late-preclinical research addressing key barriers to therapy implementation is also welcome, where proof-of-concept of the proposed therapeutic route already exists, and clinical trials of a therapy would otherwise be feasible. (Earlier-stage preclinical or basic research, are not eligible for support, nor are small-scale late-preclinical projects: such research should, instead, be submitted to DEBRA's
Research project grant scheme)
No hay comentarios:
Publicar un comentario